Stock Events

Stock Events

Protagonist Therapeutics (PTGX) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.7

0.66

2.01

3.37

Details

Expected EPS

-0.595383

Actual EPS

-0.5

Surprise EPS

0.1

Surprise Percent

+16.02%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.5 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.